Safety and Immunogenicity of Increasing Doses of a Clostridium difficile Toxoid Vaccine Administered to Healthy Adults
Clostridium difficile is a major cause of nosocomial diarrhea in industrialized countries. Although most illnesses respond to available therapy, infection can increase morbidity, prolong hospitalization, and produce life-threatening colitis. Vaccines are being explored as an alternative means for pr...
Gardado en:
| Publicado en: | Infect Immun |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
2001
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC97978/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11159994/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.69.2.988-995.2001 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
